scholarly journals Evaluation of Jatropha curcas Linn. leaf extracts for its cytotoxicity and potential to inhibit hemagglutinin protein of influenza virus

2013 ◽  
Vol 24 (2) ◽  
pp. 220-226 ◽  
Author(s):  
Deepak Patil ◽  
Soumen Roy ◽  
Ritwik Dahake ◽  
Shreewardhan Rajopadhye ◽  
Sweta Kothari ◽  
...  
2007 ◽  
Vol 146 (1-2) ◽  
pp. 293-297 ◽  
Author(s):  
Chi Y. Wang ◽  
Yu L. Luo ◽  
Yu T. Chen ◽  
Shu K. Li ◽  
Chi H. Lin ◽  
...  

2017 ◽  
Vol 07 (02) ◽  
Author(s):  
Chidi Uzoma Igwe ◽  
Linus Nwaogu ◽  
Emmanuel Uche Olunkwa ◽  
Martin Otaba ◽  
Viola Onwuliri

Viruses ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 1019
Author(s):  
Majid Forghani ◽  
Michael Khachay

Evaluation of the antigenic similarity degree between the strains of the influenza virus is highly important for vaccine production. The conventional method used to measure such a degree is related to performing the immunological assays of hemagglutinin inhibition. Namely, the antigenic distance between two strains is calculated on the basis of HI assays. Usually, such distances are visualized by using some kind of antigenic cartography method. The known drawback of the HI assay is that it is rather time-consuming and expensive. In this paper, we propose a novel approach for antigenic distance approximation based on deep learning in the feature spaces induced by hemagglutinin protein sequences and Convolutional Neural Networks (CNNs). To apply a CNN to compare the protein sequences, we utilize the encoding based on the physical and chemical characteristics of amino acids. By varying (hyper)parameters of the CNN architecture design, we find the most robust network. Further, we provide insight into the relationship between approximated antigenic distance and antigenicity by evaluating the network on the HI assay database for the H1N1 subtype. The results indicate that the best-trained network gives a high-precision approximation for the ground-truth antigenic distances, and can be used as a good exploratory tool in practical tasks.


2018 ◽  
Vol 61 (7) ◽  
pp. 836-843 ◽  
Author(s):  
Yongkun Chen ◽  
Tian Bai ◽  
Wenfei Zhu ◽  
Rongbao Gao ◽  
Zhihong Deng ◽  
...  

2016 ◽  
Vol 91 (2) ◽  
Author(s):  
Catherine M. Crosby ◽  
William E. Matchett ◽  
Stephanie S. Anguiano-Zarate ◽  
Christopher A. Parks ◽  
Eric A. Weaver ◽  
...  

ABSTRACT Head-to-head comparisons of conventional influenza vaccines with adenovirus (Ad) gene-based vaccines demonstrated that these viral vectors can mediate more potent protection against influenza virus infection in animal models. In most cases, Ad vaccines are engineered to be replication-defective (RD-Ad) vectors. In contrast, replication-competent Ad (RC-Ad) vaccines are markedly more potent but risk causing adenovirus diseases in vaccine recipients and health care workers. To harness antigen gene replication but avoid production of infectious virions, we developed “single-cycle” adenovirus (SC-Ad) vectors. Previous work demonstrated that SC-Ads amplify transgene expression 100-fold and produce markedly stronger and more persistent immune responses than RD-Ad vectors in Syrian hamsters and rhesus macaques. To test them as potential vaccines, we engineered RD and SC versions of adenovirus serotype 6 (Ad6) to express the hemagglutinin (HA) gene from influenza A/PR/8/34 virus. We show here that it takes approximately 33 times less SC-Ad6 than RD-Ad6 to produce equal amounts of HA antigen in vitro. SC-Ad produced markedly higher HA binding and hemagglutination inhibition (HAI) titers than RD-Ad in Syrian hamsters. SC-Ad-vaccinated cotton rats had markedly lower influenza titers than RD-Ad-vaccinated animals after challenge with influenza A/PR/8/34 virus. These data suggest that SC-Ads may be more potent vaccine platforms than conventional RD-Ad vectors and may have utility as “needle-free” mucosal vaccines. IMPORTANCE Most adenovirus vaccines that are being tested are replication-defective adenoviruses (RD-Ads). This work describes testing newer single-cycle adenovirus (SC-Ad) vectors that replicate transgenes to amplify protein production and immune responses. We show that SC-Ads generate markedly more influenza virus hemagglutinin protein and require substantially less vector to generate the same immune responses as RD-Ad vectors. SC-Ads therefore hold promise to be more potent vectors and vaccines than current RD-Ad vectors.


Sign in / Sign up

Export Citation Format

Share Document